Advertisement

Topics

SK Capital buys Perrigo's Israel unit Chemagis for $110m

10:15 EDT 10 Aug 2017 | Globes

The active pharmaceutical ingredients unit was bought by Perrigo as part of the $818 million acquisition of Agis in 2005.

Original Article: SK Capital buys Perrigo's Israel unit Chemagis for $110m

NEXT ARTICLE

More From BioPortfolio on "SK Capital buys Perrigo's Israel unit Chemagis for $110m"

Quick Search
Advertisement
 

Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...